Trazenta Randomized study for USing insulin patient of Type 2 Diabetes
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000010830
- Lead Sponsor
- Japan society for Patient Reported Outcome
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 244
Not provided
Person who correspond to any of following are excluded: 1.Patients who are Type I or Secondary diabetic mellitus 2.Patients who are treating with Insulin, more than 1 I.U/kg per day 3.Patients who are treating with two or more types of Insulin 4.Patients who are treating with CSII (Continuous Subcutaneous Insulin Infusion) 5.Patients who are treating with DPP-4 Inhibitor, GLP-1 and Alpha-GI at the time of study initiation 6.Patients who are severe infectious disease, perioperative, and severe trauma 7.Patients with myocardial infarction, angina pectoris, cerebral stroke, or cerebral infarction 8.Patients with severe liver dysfunction ( AST:100 IU/l or higher) 9.Patients with moderate or severer heart failure (NYHA/New York Heart Association stage 3 or severer) 10.Patients who require dialysis. 11.Patients who are pregnant, lactating, and possibly pregnant women and those planning to become pregnant 12.Patients with a history of hypersensitivity to investigational drugs. 13.Patients with cancer 14.Patients who receive steroid therapy with inflammatory affection 15.Patients whom doctor judges as ineligible to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method